<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_ventricular" title="Left Ventricular Assist Devices 101: Shared Care for General Cardiologists and Primary Care" shortTitle="ventricular" author="Aditi Singhvi, Barry Trachtenberg" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2077-0383/8/10/1720/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
8.	LS	8.
Complications	NNS	complication
of	IN	of
LVADs	NN	lVad
</s>
</head>
<p>
<s type="decl">
While	IN	while
survival	NN	survival
has	VBZ	have
improved	VBN	improve
with	IN	with
CF-LVADS	NNPS	CF-LVADS
,	,	,
the	DT	the
adverse	JJ	adverse
event	NN	event
profile	NN	profile
remains	VBZ	remain
high	JJ	high
.	.	.
</s>
<s type="decl">
At	IN	at
1	CD	1
month	NN	month
post-implant	NN	post-implant
,	,	,
nearly	RB	nearly
30	CD	30
%	NN	%
and	CC	and
at	IN	at
1	CD	1
year	NN	year
,	,	,
almost	RB	almost
80	CD	80
%	NN	%
of	IN	of
patients	NNS	patient
,	,	,
require	VBP	require
readmission	NN	readmission
.	.	.
</s>
<s type="decl">
The	DT	the
common	JJ	common
LVAD-related	JJ	LVAD-related
complications	NNS	complication
,	,	,
outside	IN	outside
of	IN	of
the	DT	the
immediate	JJ	immediate
post-operative	JJ	post-operative
period	NN	period
,	,	,
are	VBP	be
outlined	VBN	outline
in	IN	in
Table	NNP	Table
4	CD	4
.	.	.
</s>
<s type="sub">
Providers	NNS	Provider
in	IN	in
the	DT	the
community	NN	community
may	MD	may
be	VB	be
the	DT	the
first	JJ	first
medical	JJ	medical
contact	NN	contact
for	IN	for
patients	NNS	patient
with	IN	with
LVADs	NNS	lVad
experiencing	VBG	experience
a	DT	a
complication	NN	complication
.	.	.
</s>
<s type="sub">
Though	IN	though
management	NN	management
of	IN	of
these	DT	this
complications	NNS	complication
should	MD	should
be	VB	be
in	IN	in
concert	NN	concert
with	IN	with
LVAD	NNP	LVAD
specialists	NNS	specialist
,	,	,
an	DT	a
awareness	NN	awareness
and	CC	and
understanding	NN	understanding
of	IN	of
the	DT	the
common	JJ	common
complications	NNS	complication
can	MD	can
help	VB	help
with	IN	with
timely	JJ	timely
diagnosis	NN	diagnosis
and	CC	and
therapeutic	JJ	therapeutic
intervention	NN	intervention
.	.	.
</s>
</p>
<head>
<s type="frag">
8.1.	CD	8.1.
LVAD	NNP	LVAD
Infections	NNS	infection
</s>
</head>
<p>
<s type="decl">
Due	JJ	due
to	IN	to
the	DT	the
presence	NN	presence
of	IN	of
a	DT	a
percutaneous	JJ	percutaneous
driveline	NN	driveline
exiting	VBG	exit
the	DT	the
skin	NN	skin
,	,	,
infections	NNS	infection
remain	VBP	remain
the	DT	the
Achilles	NNP	Achilles
heel	NN	heel
of	IN	of
LVADs	NNPS	LVADs
.	.	.
</s>
<s type="decl">
Recent	JJ	Recent
implantation	NN	implantation
of	IN	of
the	DT	the
first-in-man	JJ	first-in-man
totally	RB	totally
implantable	JJ	implantable
LVAD	NNP	LVAD
aims	VBZ	aim
to	TO	to
minimize	VB	minimize
this	DT	this
risk	NN	risk
.	.	.
</s>
<s type="decl">
ISHLT	NNP	ISHLT
classifies	VBZ	classify
infections	NNS	infection
in	IN	in
LVAD	NNP	LVAD
patients	NNS	patient
as	IN	as
VAD-specific	JJ	VAD-specific
(	-LRB-	(
involving	VBG	involve
the	DT	the
pump	NN	pump
,	,	,
cannula	NN	cannula
,	,	,
pocket	NN	pocket
,	,	,
or	CC	or
percutaneous	JJ	percutaneous
driveline	NN	driveline
)	-RRB-	)
,	,	,
VAD-related	JJ	VAD-related
(	-LRB-	(
infective	JJ	infective
endocarditis	NN	endocarditis
,	,	,
blood	NN	blood
stream	NN	stream
infections	NNS	infection
including	VBG	include
central	JJ	central
venous	JJ	venous
catheter	NN	catheter
associated	VBN	associate
,	,	,
mediastinitis	NN	mediastinitis
)	-RRB-	)
and	CC	and
non-VAD	JJ	non-VAD
infections	NNS	infection
such	JJ	such
as	IN	as
pneumonia	NN	pneumonia
.	.	.
</s>
</p>
<p>
<s type="decl">
Different	JJ	different
techniques	NNS	technique
,	,	,
largely	RB	largely
limited	VBN	limit
to	IN	to
single-center	JJ	single-center
experiences	NNS	experience
,	,	,
have	VBP	have
been	VBN	be
shown	VBN	show
to	TO	to
reduce	VB	reduce
infection	NN	infection
rates	NNS	rate
and	CC	and
there	EX	there
is	VBZ	be
no	DT	no
universal	JJ	universal
protocol	NN	protocol
.	.	.
</s>
<s type="decl">
Risk	NN	risk
factors	NNS	factor
for	IN	for
driveline	NN	driveline
infection	NN	infection
include	VBP	include
trauma	NN	trauma
to	IN	to
the	DT	the
driveline	NN	driveline
exit	NN	exit
site	NN	site
,	,	,
younger	JJR	young
age	NN	age
,	,	,
higher	JJR	high
body	NN	body
mass	NN	mass
index	NN	index
and	CC	and
exposed	VBN	expose
driveline	NN	driveline
velour	NN	velour
.	.	.
</s>
<s type="decl">
Meticulous	JJ	meticulous
exit	NN	exit
site	NN	site
and	CC	and
driveline	NN	driveline
care	NN	care
and	CC	and
driveline	NN	driveline
immobilization	NN	immobilization
are	VBP	be
advised	VBN	advise
to	TO	to
reduce	VB	reduce
the	DT	the
risk	NN	risk
of	IN	of
infection	NN	infection
.	.	.
</s>
</p>
<p>
<s type="multiple">
Driveline	NN	driveline
drainage	NN	drainage
culture	NN	culture
and	CC	and
blood	NN	blood
cultures	NNS	culture
should	MD	should
be	VB	be
obtained	VBN	obtain
,	,	,
and	CC	and
imaging	NN	imaging
may	MD	may
be	VB	be
needed	VBN	need
as	RB	as
well	RB	well
.	.	.
</s>
<s type="decl">
It	PRP	it
is	VBZ	be
important	JJ	important
to	TO	to
note	VB	note
that	IN	that
driveline	NN	driveline
site	NN	site
assessment	NN	assessment
and	CC	and
obtaining	VBG	obtain
specimens	NNS	specimen
of	IN	of
the	DT	the
drainage	NN	drainage
should	MD	should
only	RB	only
be	VB	be
performed	VBN	perform
by	IN	by
members	NNS	member
of	IN	of
the	DT	the
LVAD	NNP	LVAD
team	NN	team
(	-LRB-	(
or	CC	or
designated	VBN	designate
shared	VBN	share
care	NN	care
centers	NNS	center
)	-RRB-	)
in	IN	in
order	NN	order
to	TO	to
limit	VB	limit
the	DT	the
number	NN	number
of	IN	of
times	NNS	time
and	CC	and
the	DT	the
number	NN	number
of	IN	of
people	NNS	person
to	IN	to
whom	WP	who
the	DT	the
driveline	NN	driveline
is	VBZ	be
exposed	VBN	expose
.	.	.
</s>
<s type="decl">
Culture	NN	Culture
of	IN	of
any	DT	any
drainage	NN	drainage
is	VBZ	be
recommended	VBN	recommend
.	.	.
</s>
<s type="decl">
Abnormal	JJ	abnormal
swelling	NN	swelling
of	IN	of
the	DT	the
region	NN	region
surrounding	VBG	surround
the	DT	the
driveline	NN	driveline
site	NN	site
should	MD	should
be	VB	be
assessed	VBN	assess
by	IN	by
imaging	NN	imaging
studies	NNS	study
(	-LRB-	(
i.e.	FW	i.e.
,	,	,
ultrasound	NN	ultrasound
,	,	,
CT	NN	CT
scan	NN	scan
or	CC	or
PET	NN	PET
scan	NN	scan
)	-RRB-	)
to	TO	to
assess	VB	assess
the	DT	the
presence	NN	presence
,	,	,
extent	NN	extent
,	,	,
and	CC	and
appearance	NN	appearance
of	IN	of
any	DT	any
fluid	NN	fluid
collections	NNS	collection
.	.	.
</s>
<s type="decl">
Blood	NN	blood
cultures	NNS	culture
are	VBP	be
important	JJ	important
to	TO	to
evaluate	VB	evaluate
for	IN	for
occult	JJ	occult
bloodstream	NN	bloodstream
infections	NNS	infection
,	,	,
because	IN	because
LVAD	NNP	LVAD
patients	NNS	patient
may	MD	may
not	RB	not
present	VB	present
with	IN	with
typical	JJ	typical
signs	NNS	sign
and	CC	and
symptoms	NNS	symptom
.	.	.
</s>
<s type="decl">
Typical	JJ	typical
pathogens	NNS	pathogen
are	VBP	be
skin	NN	skin
flora	NNS	flora
like	IN	like
coagulase-negative	JJ	coagulase-negative
Staphylococci	NNP	Staphylococci
and	CC	and
<hi rend="italic">
Staphylococcus	NNP	Staphylococcus
aureus	NN	aureus
.	.	.
</hi>
</s>
<s type="decl">
Gram-negative	JJ	Gram-negative
organisms	NNS	organism
like	IN	like
<hi rend="italic">
Pseudomonas	NNP	Pseudomonas
</hi>
spp.	NNS	spp.
and	CC	and
Enterobacteriaceae	NNP	Enterobacteriaceae
,	,	,
and	CC	and
fungal	JJ	fungal
infections	NNS	infection
can	MD	can
also	RB	also
occur	VB	occur
.	.	.
</s>
<s type="decl">
Surgical	JJ	Surgical
evaluation	NN	evaluation
for	IN	for
debridement	NN	debridement
of	IN	of
the	DT	the
driveline	NN	driveline
exit	NN	exit
site	NN	site
may	MD	may
be	VB	be
needed	VBN	need
depending	VBG	depend
on	IN	on
the	DT	the
extent	NN	extent
of	IN	of
the	DT	the
infection	NN	infection
,	,	,
and	CC	and
should	MD	should
be	VB	be
performed	VBN	perform
by	IN	by
a	DT	a
surgical	JJ	surgical
team	NN	team
with	IN	with
LVAD	NNP	LVAD
experience	NN	experience
.	.	.
</s>
<s type="sub">
Infectious	JJ	infectious
diseases	NNS	disease
consultation	NN	consultation
may	MD	may
be	VB	be
needed	VBN	need
,	,	,
particularly	RB	particularly
in	IN	in
the	DT	the
case	NN	case
of	IN	of
polymicrobial	JJ	polymicrobial
infections	NNS	infection
or	CC	or
multidrug-resistant	JJ	multidrug-resistant
organisms	NNS	organism
.	.	.
</s>
<s type="sub">
If	IN	if
bacteremia	NN	bacteremia
or	CC	or
sepsis	NN	sepsis
are	VBP	be
present	JJ	present
,	,	,
a	DT	a
chest	NN	chest
and	CC	and
abdomen	NN	abdomen
CT	NN	CT
,	,	,
transthoracic	JJ	transthoracic
and	CC	and
even	RB	even
transesophageal	JJ	transesophageal
echocardiogram	NN	echocardiogram
should	MD	should
be	VB	be
obtained	VBN	obtain
to	TO	to
evaluate	VB	evaluate
for	IN	for
the	DT	the
source	NN	source
of	IN	of
the	DT	the
infection	NN	infection
(	-LRB-	(
especially	RB	especially
in	IN	in
patients	NNS	patient
with	IN	with
pacemaker	NN	pacemaker
or	CC	or
defibrillator	NN	defibrillator
leads	NNS	lead
)	-RRB-	)
.	.	.
</s>
<s type="decl">
There	EX	there
is	VBZ	be
an	DT	a
emerging	VBG	emerge
role	NN	role
for	IN	for
PET	NNP	PET
imaging	NN	imaging
with	IN	with
F-18	NNP	F-18
labeled	VBN	label
fluoro-2-deoxyglucose	NN	fluoro-2-deoxyglucose
.	.	.
</s>
<s type="decl">
VAD	NN	vad
infections	NNS	infection
are	VBP	be
biofilm-based	JJ	biofilm-based
and	CC	and
difficult	JJ	difficult
to	TO	to
eradicate	VB	eradicate
.	.	.
</s>
<s type="decl">
Treatment	NN	treatment
strategies	NNS	strategy
for	IN	for
VAD	NN	vad
infections	NNS	infection
include	VBP	include
intravenous	JJ	intravenous
antibiotics	NNS	antibiotics
followed	VBN	follow
by	IN	by
oral	JJ	oral
suppression	NN	suppression
in	IN	in
tandem	NN	tandem
with	IN	with
surgical	JJ	surgical
debridement	NN	debridement
.	.	.
</s>
<s type="decl">
Infections	NNS	infection
tend	VBP	tend
to	TO	to
be	VB	be
recurrent	JJ	recurrent
despite	IN	despite
debridement	NN	debridement
,	,	,
with	IN	with
Pseudomonas	NNP	Pseudomonas
infection	NN	infection
in	IN	in
particular	JJ	particular
,	,	,
showing	VBG	show
a	DT	a
lower	JJR	low
success	NN	success
rate	NN	rate
.	.	.
</s>
<s type="decl">
The	DT	the
role	NN	role
of	IN	of
pump	NN	pump
exchange	NN	exchange
is	VBZ	be
not	RB	not
clearly	RB	clearly
defined	VBN	define
.	.	.
</s>
<s type="decl">
One	CD	one
study	NN	study
noted	VBD	note
a	DT	a
particularly	RB	particularly
poor	JJ	poor
prognosis	NN	prognosis
with	IN	with
candidemia	NN	candidemia
and	CC	and
concomitant	JJ	concomitant
presence	NN	presence
of	IN	of
a	DT	a
cardiac-implanted	JJ	cardiac-implanted
electronic	JJ	electronic
device	NN	device
,	,	,
and	CC	and
failure	NN	failure
to	TO	to
remove	VB	remove
the	DT	the
device	NN	device
during	IN	during
pump	NN	pump
exchange	NN	exchange
was	VBD	be
associated	VBN	associate
with	IN	with
poor	JJ	poor
outcomes	NNS	outcome
in	IN	in
65	CD	65
%	NN	%
of	IN	of
patients	NNS	patient
.	.	.
</s>
</p>
<p>
<s type="decl">
Some	DT	some
studies	NNS	study
have	VBP	have
shown	VBN	show
that	IN	that
LVAD	NNP	LVAD
infections	NNS	infection
adversely	RB	adversely
affect	VB	affect
survival	NN	survival
after	IN	after
adjusting	VBG	adjust
for	IN	for
age	NN	age
and	CC	and
comorbidities	NNS	comorbidity
.	.	.
</s>
<s type="decl">
One	CD	one
prospective	JJ	prospective
study	NN	study
showed	VBD	show
a	DT	a
22	CD	22
%	NN	%
overall	JJ	overall
infection	NN	infection
rate	NN	rate
of	IN	of
LVADs	NNS	lVad
and	CC	and
a	DT	a
5.6-times	CD	5.6-time
greater	JJR	great
1-year	NN	1-year
mortality	NN	mortality
in	IN	in
patients	NNS	patient
with	IN	with
infections	NNS	infection
.	.	.
</s>
<s type="decl">
Besides	IN	besides
mortality	NN	mortality
,	,	,
LVAD	NNP	LVAD
infections	NNS	infection
are	VBP	be
associated	VBN	associate
with	IN	with
a	DT	a
greater	JJR	great
risk	NN	risk
of	IN	of
pump	NN	pump
thrombosis	NN	thrombosis
,	,	,
bleeding	NN	bleeding
complications	NNS	complication
,	,	,
prolonged	VBN	prolong
hospitalization	NN	hospitalization
,	,	,
need	NN	need
for	IN	for
pump	NN	pump
exchange	NN	exchange
,	,	,
and	CC	and
failure	NN	failure
to	TO	to
achieve	VB	achieve
transplantation	NN	transplantation
.	.	.
</s>
<s type="decl">
Bloodstream	NN	bloodstream
infections	NNS	infection
,	,	,
in	IN	in
particular	JJ	particular
,	,	,
are	VBP	be
associated	VBN	associate
with	IN	with
stroke	NN	stroke
and	CC	and
increased	VBN	increase
mortality	NN	mortality
.	.	.
</s>
<s type="decl">
Despite	IN	despite
these	DT	this
risks	NNS	risk
,	,	,
the	DT	the
presence	NN	presence
of	IN	of
an	DT	a
LVAD	NNP	LVAD
infection	NN	infection
has	VBZ	have
not	RB	not
been	VBN	be
shown	VBN	show
to	TO	to
have	VB	have
a	DT	a
negative	JJ	negative
impact	NN	impact
on	IN	on
post-transplant	JJ	post-transplant
outcomes	NNS	outcome
.	.	.
</s>
</p>
<head>
<s type="frag">
8.2.	CD	8.2.
Gastrointestinal	JJ	Gastrointestinal
(	-LRB-	(
GI	NNP	GI
)	-RRB-	)
Bleed	NN	bleed
</s>
</head>
<p>
<s type="decl">
GI	NNP	GI
bleed	NN	bleed
is	VBZ	be
one	CD	one
of	IN	of
the	DT	the
most	RBS	most
frequent	JJ	frequent
complications	NNS	complication
after	IN	after
LVAD	NNP	LVAD
implant	NN	implant
and	CC	and
the	DT	the
most	RBS	most
common	JJ	common
reason	NN	reason
for	IN	for
hospital	NN	hospital
readmission	NN	readmission
.	.	.
</s>
<s type="decl">
It	PRP	it
is	VBZ	be
triggered	VBN	trigger
by	IN	by
the	DT	the
use	NN	use
of	IN	of
antiplatelet	NN	antiplatelet
and	CC	and
anticoagulant	JJ	anticoagulant
therapy	NN	therapy
.	.	.
</s>
<s type="decl">
Additionally	RB	additionally
,	,	,
CF-LVADs	NNPS	CF-LVADs
can	MD	can
cause	VB	cause
acquired	VBN	acquire
von	NNP	von
Willebrand	NNP	Willebrand
factor	NN	factor
deficiency	NN	deficiency
due	JJ	due
to	IN	to
the	DT	the
high	JJ	high
shear	NN	shear
stress	NN	stress
imposed	VBN	impose
by	IN	by
the	DT	the
LVAD	NNP	LVAD
motor	NN	motor
,	,	,
resulting	VBG	result
in	IN	in
breakdown	NN	breakdown
of	IN	of
large	JJ	large
von	NN	von
Willebrand	NNP	Willebrand
factor	NN	factor
multimers	NNS	multimer
.	.	.
</s>
<s type="decl">
Also	RB	also
,	,	,
continuous	JJ	continuous
flow	NN	flow
physiology	NN	physiology
and	CC	and
dysregulation	NN	dysregulation
of	IN	of
angiogenic	JJ	angiogenic
factors	NNS	factor
have	VBP	have
been	VBN	be
shown	VBN	show
to	TO	to
lead	VB	lead
to	IN	to
development	NN	development
of	IN	of
arteriovenous	JJ	arteriovenous
malformations	NNS	malformation
(	-LRB-	(
AVMs	NNS	avm
)	-RRB-	)
in	IN	in
the	DT	the
gastrointestinal	JJ	gastrointestinal
tract	NN	tract
,	,	,
nasopharynx	NN	nasopharynx
,	,	,
brain	NN	brain
,	,	,
and	CC	and
other	JJ	other
tissues	NNS	tissue
.	.	.
</s>
</p>
</text>